文献速递乳房整形与再造显微修复重建

微血管乳房重建术后最佳住院时长:成本-效用分析

The Optimal Length of Stay after Microvascular Breast Reconstruction: A Cost-Utility Analysis.
PubMed 文献 · Plast Reconstr Surg · 2022-06-03

该研究采用决策树模型,从医院视角评估微血管乳房重建术后不同住院时长策略的成本-效用。健康状态概率来自机构病历回顾。结果显示,术后3天住院是最具成本-效用的策略,期望成本为41,680.19美元,期望健康效用为25.68质量调整生命年。蒙特卡洛敏感性分析证实,在支付意愿阈值为每获得1个质量调整生命年50,000至130,000美元时,多数模拟中术后第3天出院最具成本-效用。

要点

  • 微血管乳房重建术后3天住院是最具成本-效用的策略。
  • 该策略期望成本为41,680.19美元,期望效用为25.68质量调整生命年。
  • 支付意愿阈值50,000至130,000美元/质量调整生命年时,多数模拟支持术后第3天出院。

核心结论

  • 该成本-效用分析提示,微血管乳房重建术后3天住院是最具成本-效用的策略。

研究设计与样本

  • 采用决策树模型,从医院视角评估多种住院时长策略的成本-效用。
  • 健康状态概率通过机构病历回顾估计。
  • 使用蒙特卡洛模拟和敏感性分析评估期望成本与质量调整生命年。

主要发现

  • 10年期间,总体皮瓣丢失率为1.6%,再手术率为4.9%。
  • 回溯分析后,3天住院被确定为最具成本-效用的策略,期望成本为41,680.19美元,期望健康效用为25.68质量调整生命年。
  • 蒙特卡洛敏感性分析证实,当支付意愿阈值在每获得1个质量调整生命年50,000至130,000美元之间变化时,多数模拟中术后第3天出院是最具成本-效用的策略。

关键数值与推荐

  • 3天住院策略的期望成本为41,680.19美元,期望健康效用为25.68质量调整生命年。
  • 支付意愿阈值为每获得1个质量调整生命年50,000至130,000美元。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Length of stay can have a large impact on overall surgical costs. Several studies have demonstrated that a shortened length of stay is safe and effective after microvascular breast reconstruction. The optimal length of stay from a cost-utility perspective is not known. METHODS: The authors used a decision tree model to evaluate the cost-utility, from the perspective of the hospital, of a variety of length-of-stay strategies. Health state probabilities were estimated from an institutional chart review. Expected costs and quality-adjusted life-years were assessed using Monte Carlo simulation and sensitivity analyses. RESULTS: Over a 10-year period, the authors' overall flap loss and take-back rates were 1.6 percent and 4.9 percent, respectively. After rollback, a 3-day length of stay was identified as the most cost-effective strategy, with an expected cost of $41,680.19 and an expected health utility of 25.68 quality-adjusted life-years. Monte Carlo sensitivity analysis confirmed that discharge on postoperative day 3 was the most cost-effective strategy in the majority of simulations when the willingness-to-pay threshold varied from $50,000 to $130,000 per quality-adjusted life-year gained. CONCLUSION: This cost-utility analysis suggests that a 3-day length of stay is the most cost-effective strategy after microvascular breast reconstruction.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Mericli AF, Selber JC, Largo RD, et al. The Optimal Length of Stay after Microvascular Breast Reconstruction: A Cost-Utility Analysis. Plast Reconstr Surg. 2022. PMID: 35653514. doi:10.1097/PRS.0000000000009316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。